Cargando…

KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B

To date, several on-treatment-level virological and serological indices that may predict the response to interferon alpha (IFN-α) have been reported. However, no effective predictors, such as drug–response genes, that can be detected before administration of anti-hepatitis B virus (HBV) therapy with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Wenting, Shen, Xiaokun, Fu, Binqing, Guo, Chuang, Liu, Yanyan, Ye, Ying, Sun, Rui, Li, Jiabin, Tian, Zhigang, Wei, Haiming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641573/ https://www.ncbi.nlm.nih.gov/pubmed/29075265 http://dx.doi.org/10.3389/fimmu.2017.01285

Ejemplares similares

NKp30(+) NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B
por: Shen, Xiaokun, et al.
Publicado: (2016)

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
por: Erbe, Amy K., et al.
Publicado: (2017)

CD3(bright)CD56(+) T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients
por: Guo, Chuang, et al.
Publicado: (2016)

Behçet’s disease in HLA-B*51 negative Germans and Turks shows association with HLA-Bw4-80I
por: Kuranov, Alexandr Borisovich, et al.
Publicado: (2014)

KIR3DS1-Mediated Recognition of HLA-*B51: Modulation of KIR3DS1 Responsiveness by Self HLA-B Allotypes and Effect on NK Cell Licensing
por: Carlomagno, Simona, et al.
Publicado: (2017)

KIR3DS1/L1 and HLA-Bw4-80I are associated with HIV disease progression among HIV typical progressors and long-term nonprogressors
por: Jiang, Yongjun, et al.
Publicado: (2013)

Advances in Immunotherapy for Hepatitis B
por: Wang, Dongyao, et al.
Publicado: (2022)

Peptide-Dependent Recognition of HLA-B*57:01 by KIR3DS1
por: O'Connor, Geraldine M., et al.
Publicado: (2015)

HLA-B*44 and the Bw4-80T motif are associated with poor outcome of relapse-preventive immunotherapy in acute myeloid leukemia
por: Komic, Hana, et al.
Publicado: (2023)

HLA-B, HLA-C and KIR improve the predictive value of IFNL3 for Hepatitis C spontaneous clearance
por: Frias, Mario, et al.
Publicado: (2018)

Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24(+)CD38(hi) B Cells
por: Fu, Binqing, et al.
Publicado: (2020)

Activating KIR and HLA Bw4 Ligands Are Associated to Decreased Susceptibility to Pemphigus Foliaceus, an Autoimmune Blistering Skin Disease
por: Augusto, Danillo G., et al.
Publicado: (2012)

Restoration of HBV-specific CD8(+) T-cell responses by sequential low-dose IL-2 treatment in non-responder patients after IFN-α therapy
por: Wang, Dongyao, et al.
Publicado: (2021)

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
por: Erbe, Amy K., et al.
Publicado: (2019)

Association analysis of KIR/HLA genotype with liver cirrhosis, hepatocellular carcinoma, and NUC freedom in chronic hepatitis B patients
por: Joshita, Satoru, et al.
Publicado: (2021)

Are the KIR3DS1homozygous and KIR3DL1*h/*y+HLA-B*57 genotypes associated protection from HIV by different routes of exposure?
por: Tallon, B, et al.
Publicado: (2012)

KIR and HLA Loci Are Associated with Hepatocellular Carcinoma Development in Patients with Hepatitis B Virus Infection: A Case-Control Study
por: Pan, Ning, et al.
Publicado: (2011)

Donor KIR3DL1/receptor HLA-Bw4-80I Combination Reduces Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-cell Depletion
por: Fang, Xinchen, et al.
Publicado: (2021)

Cytoplasm-Translocated Ku70/80 Complex Sensing of HBV DNA Induces Hepatitis-Associated Chemokine Secretion
por: Li, Young, et al.
Publicado: (2016)

KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
por: Umemura, Takeji, et al.
Publicado: (2019)

Distribution of HLA-A, -B, and -C Alleles and HLA/KIR Combinations in Han Population in China
por: Shen, Yunsong, et al.
Publicado: (2014)

KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in HLA-B Bw4 Homozygous Individuals
por: Zhang, Xin, et al.
Publicado: (2018)

NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80
Publicado: (1994)

KIR, HLA, and IL28B Variant Predict Response to Antiviral Therapy in Genotype 1 Chronic Hepatitis C Patients in Japan
por: Nozawa, Yuichi, et al.
Publicado: (2013)

The killer immunoglobulin-like receptor KIR3DL1 combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
por: Hollenbach, Jill A., et al.
Publicado: (2016)

KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han
por: Zhen, Jian Xin, et al.
Publicado: (2020)

HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19
por: Wang, Ruihua, et al.
Publicado: (2023)

The Loss of HLA-F/KIR3DS1 Ligation Is Mediated by Hemoglobin Peptides
por: Hò, Gia-Gia T., et al.
Publicado: (2020)

Time to Seroconversion in HIV-Exposed Subjects Carrying Protective versus Non Protective KIR3DS1/L1 and HLA-B Genotypes
por: Tallon, Benjamin J. M., et al.
Publicado: (2014)

The top decay t --> bW in the two Higgs doublet model
por: Denner, A, et al.
Publicado: (1993)

Association of KIR2DL5, KIR2DS5, and KIR2DS1 allelic variation and atopic dermatitis
por: Margolis, David J., et al.
Publicado: (2023)

Rituximab response in follicular lymphoma: contributions from KIR 2DS1 and HLA-C
por: Erbe, A K, et al.
Publicado: (2013)

KIR2DS5 in the presence of HLA-C C2 protects against endometriosis
por: Nowak, Izabela, et al.
Publicado: (2015)

Prospective cohort study of prevention of mother to child transmission of hepatitis B infection and 9 months follow-up of hepatitis B-exposed infants at Ile-Ife, Nigeria
por: Ndububa, Dennis, et al.
Publicado: (2022)

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
por: Graef, Thorsten, et al.
Publicado: (2009)

The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
Publicado: (1995)

Immunoinformatic Docking Approach for the Analysis of KIR3DL1/HLA-B Interaction
por: Grifoni, Alba, et al.
Publicado: (2013)

KIR genotype distribution among patients with multiple myeloma: Higher prevalence of KIR 2DS4 and KIR 2DS5 genes
por: Hoteit, R., et al.
Publicado: (2014)

Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases
por: De Re, Valli, et al.
Publicado: (2015)

Association of KIR2DS1 and KIR2DS3 with fatal outcome in Ebola virus infection
por: Wauquier, Nadia, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_3vij5u9us6vjumb9b0l6hfugl1